- 18 Mar 2013 Appointments strengthen drug development
- 4 Feb 2013 Kymab Access to support academic translation
- 5 Dec 2012 Kymouse™ data at antibody engineering conference
- 30 Nov 2012 Financial Times: Of mice, men and medicine
- 29 Oct 2012 Kymab strengthens Board of Directors
- 30 Mar 2012 Milestone in Kymouse human antibody platform
- 28 Feb 2012 BioCentury ‘Emerging Company’ profile
- 30 Nov 2011 Allan Bradley appointed Chief Scientific Officer
- 18 Jan 2011 Kymab opens Cambridge R&D facility
- 12 Jul 2010 Wellcome Trust £20 million financing agreement